asperuloside has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| da SilvaTorres, IL; de Oliveira, JDM; Medeiros, HR; Pereira, P; Pflüger, P; Picada, JN; Uczay, M; Vendruscolo, MH; von Poser, G | 1 |
| Bhat, NG; Fokou, PVT; Kumar, NVA; Manzione, MG; Martorell, M; Pezzani, R; Sharopov, F | 1 |
| Chen, C; Chi, G; Feng, H; Qiu, J; Ren, Y; Wu, Q | 1 |
1 review(s) available for asperuloside and Disease Models, Animal
| Article | Year |
|---|---|
Phytochemical and pharmacological properties of asperuloside, a systematic review.
Topics: Animals; Cyclopentane Monoterpenes; Disease Models, Animal; Glucosides; Humans; Phytochemicals; Pyrans | 2020 |
3 other study(ies) available for asperuloside and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Geniposide and asperuloside alter the COX-2 and GluN2B receptor expression after pilocarpine-induced seizures in mice.
Topics: Animals; Cyclooxygenase 2; Disease Models, Animal; Hippocampus; Iridoids; Mice; Pilocarpine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures | 2023 |
Pretreatment with the compound asperuloside decreases acute lung injury via inhibiting MAPK and NF-κB signaling in a murine model.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cell Line; Cyclopentane Monoterpenes; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Humans; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred BALB C; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peroxidase; Pyrans; Signal Transduction; Tumor Necrosis Factor-alpha | 2016 |